ResQ Medical

CONTROLLING THE BLEEDING IN TIME

RESQ-MEDICAL

ResQ Medical is an Israeli startup company established in August 2022 with the support of the Israel Innovation Authority (IIA) and Youdim Pharmaceuticals a private professional leading investor in the medical field. The company developed a safe, effective, cutting-edge device for treating Postpartum Hemorrhage (PPH).
Our goal is to become an essential tool in every delivery room & the first choice in the treatment of PPH and alleviate the risks and the potential complications to which millions of women each year are exposed during delivery.

Market and Business Opportunity

The global market for postpartum hemorrhage devices expected to exceed $1.35 billion by 2030, CAGR of 5.4% over the forecast period. Further, the increasing rate of complications in pregnancies is a major factor driving the demand for postpartum hemorrhage devices, thereby contributing to market growth. It is estimated that nearly 5% of women giving birth in the United States develop PPH after giving birth, meaning about 200,000 women a year in the US alone!

The Need

  • Before undertaking surgical operations, an attempt is made to stop the bleeding using dedicated devices, from which the go to device today is the Uterine balloon Tamponade (UBT) , an expanding balloon that aims to control bleeding by compressing the intrauterine blood vessels.
  • These solutions essentially work against the body’s natural mechanism of contracting the uterus to stop bleeding, resulting in a significant failure rate of 30%. The market is in need of an effective, reliable, easy-to-use, and affordable solution!

    • Alma

    An innovative device which is attentive to the physiology and anatomy.
    The mode of operation mimics the contraction of the uterus for stopping the bleeding as occurring naturally in any normal birth.

    Advantages

    Mimicking Natural Uterine Contraction to Control PPH:

  • Facilitates uterine contraction to compress and close leaking blood vessels
    Safe and Efficient:

  • The semi-flexible anatomical design supports natural uterine contractions, reducing recovery time
  • Continuous low-level vacuum promotes controlled and safe uterine collapse

    • Simple and Intuitive Operation:

  • Easy insertion and removal
  • Cost-effective solution

    • Seeking

    • Strategic collaboration
    • Investment for IND

    www.Resq-Med.com

    222

    Investment Profile

    • Validated patient need
    • Superior performance over current solutions
    • Highly experienced management team

    Intellectual Property

    Strong IP portfolio.

    Management Team

    • Dr. Itamar Dach (DVM), CEO, Co-founder More than 13 years’ experience in the medical device arena, fulfilling a wide range of roles:Field marketing specialist, Upstream Marking-Philips Healthcare,Senior field service- Volcano,Product specialist-SyncRx,CRA and preclinical coordinator -Navotek Medical,

      CRE-Biocontrol Medical

    • Dr. Amnon Weichselbaum, CTO, Co-founder Over 20 years of hands-on experience in the Israeli medicalstart-up industry. Former CTO & Business Development Director at OFEK technological incubator,Migdal HaEmek, Israel.• CEO of Aqueduct Medical

      • Co-founder of Fertiligent, CBF Medical, Bacterioscan, Ferticool

    • Mr. Tal Youdim (ENG), VP-R&D, Co-founder An expert in the area of medical devices with vast experience in engineering. In the past he has worked on development of mitral valve replacement & repair technology, Central venous catheter technology and drug device combinations targeting neurodegenerative disease drugs. He is the co-founder of several company’s including Endopump, Exegiline and Neuroptic.
    • Dr. Ali Mafra, Co-Founder
      Specialized in Obstetrics and Gynecology. Earned his MD at Hadassah Medical school, Jerusalem. MPH at Haifa university, Israel. His main interest is fetal ultrasound.Dr. Mafra is senior doctor at Ob/Gyn department, Hillel Yaffe hospital, Hadera, Israel. During his carrier he participate in several congresses and won academic rewards including the best resident, Israel Medicine Association, 2014.
    • Prof. Michael Stark, Medical Advisor Specialized in Obstetrics and Gynecology. In the years 1983-2000 he was the director of Ob/Gyn department of the Misgav Ladach Hospital in Jerusalem, and between 2001 and 2009 the chairman of Gynecology at the HELIOS, European Hospital Group.Currently, the President of the New European Surgical Academy (NESA), an international inter-disciplinary surgical academy. Prof. Stark was the scientific advisor of the European novel Tele-surgical system, scientific and medical advisor of the ELSAN, a 120-hospital group in France and is a guest scientist at the Charite’s University hospital in Berlin.
    • Dr. Roy Z. Mansano, Medical advisor Double board certified in Obstetrician/Gynecologist and Maternal-Fetal Medicine Perinatology. Owner of the Comprehensive Maternal Fetal Medicine Center which provides care for patients throughout Los Angeles and Ventura counties with affiliations of 7 large medical centers including Tarzana Providence Cedar Sinai Medical Center, Olive-View UCLA, Medical Center and Los Robles Medical Center where he is the perinatal director. He received his medical degree from Technion-Israel Inst of Technology Faculty of Medicine and has been in practice for more than 20 years.

    Contact

    Email – itamar@resq-med.com